This growth inhibition was accompanied by a significant reduction in the number of α-SMA positive tumour blood vessels and a reduction in the percentage of tumour vessels perfused at the time of tumour excision, demonstrating that target inhibition had been achieved and that inhibition of PDGFR signalling with MLN0518 has an anti-vascular effect. This evidence concerns the gene PDGFRB and neoplasm.